Search Results

There are 26977 results for: content related to: Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1

  1. You have free access to this content
    Extending our confidence in sustained virological response

    Liver International

    Volume 36, Issue 6, June 2016, Pages: 794–797, Raoel Maan and Adriaan J. van der Meer

    Version of Record online : 13 MAY 2016, DOI: 10.1111/liv.13105

  2. Changes in patient backgrounds may increase the incidence of HCC after SVR in the era of IFN-free therapy for HCV

    Hepatology

    Volume 64, Issue 5, November 2016, Pages: 1818–1819, Hidenori Toyoda, Takashi Kumada and Toshifumi Tada

    Version of Record online : 7 JUN 2016, DOI: 10.1002/hep.28632

  3. You have free access to this content
    Predicting treatment outcome following 24 weeks peginterferon α-2a/ribavirin therapy in patients infected with HCV genotype 1: Utility of HCV-RNA at day 0, day 22, day 29, and week 6

    Hepatology

    Volume 45, Issue 1, January 2007, Pages: 258–259, Esther Lukasiewicz, Kristoffer Hellstrand, Johan Westin, Carlo Ferrari, Avidan U. Neumann, Jean-michel Pawlotsky, Solko W. Schalm, Stefan Zeuzem, Bart J. Veldt, Bettina E. Hansen, Elke Verhey-hart and Martin Lagging

    Version of Record online : 22 DEC 2006, DOI: 10.1002/hep.21505

  4. You have free access to this content
    Hepatitis C virus genotype 2/3 patients who can receive an abbreviated course of peginterferon/ribavirin: The important role of initial ribavirin doses

    Hepatology

    Volume 51, Issue 5, May 2010, Pages: 1861–1862, Chia-Yen Dai, Chung-Feng Huang, Jee-Fu Huang, Wan-Long Chuang and Ming-Lung Yu

    Version of Record online : 23 FEB 2010, DOI: 10.1002/hep.23620

  5. You have free access to this content
    Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: Really safe and effective?

    Hepatology

    Volume 50, Issue 3, September 2009, Page: 988, Gin-Ho Lo

    Version of Record online : 15 JUN 2009, DOI: 10.1002/hep.23125

  6. You have free access to this content
    Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns

    Hepatology

    Volume 49, Issue 6, June 2009, Page: 2125, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming-Yen Hsieh and Ming-Lung Yu

    Version of Record online : 28 MAY 2009, DOI: 10.1002/hep.22826

  7. You have free access to this content
    Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection

    Hepatology

    Volume 53, Issue 3, March 2011, Pages: 1067–1068, Martin Lagging, Åsa Alsiö, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl, Kristine Mørch, Kristoffer Hellstrand and Gunnar Norkrans

    Version of Record online : 28 DEC 2010, DOI: 10.1002/hep.23962

  8. You have free access to this content
    Reply:

    Hepatology

    Volume 50, Issue 3, September 2009, Pages: 988–989, Bruce R. Bacon

    Version of Record online : 2 JUL 2009, DOI: 10.1002/hep.23149

  9. You have free access to this content
    Hepatitis C recurrence: Influence of serum cholesterol levels and liver steatosis on antiviral therapy

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1409–1410, Gianni Testino and Paolo Borro

    Version of Record online : 28 DEC 2010, DOI: 10.1002/hep.24034

  10. You have free access to this content
    Reply

    Hepatology

    Volume 61, Issue 1, January 2015, Page: 409, Jacinta A. Holmes, Gail V. Matthews, Alexander J. Thompson and on behalf of the CHARIOT Study Group

    Version of Record online : 20 NOV 2014, DOI: 10.1002/hep.27255

  11. You have free access to this content
    Postinterferon α-fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: Cause or results?

    Hepatology

    Volume 60, Issue 2, August 2014, Pages: 762–763, Hidenori Toyoda, Takashi Kumada and Toshifumi Tada

    Version of Record online : 18 JUN 2014, DOI: 10.1002/hep.27064

  12. You have free access to this content
    Reply

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 980–981, Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 23 FEB 2012, DOI: 10.1002/hep.25524

  13. Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient

    Liver Transplantation

    Volume 22, Issue 2, February 2016, Pages: 252–253, Salvatore Sollima, Laura Milazzo, Alessandro Torre, Elisa Calvi, Enrico Regalia and Spinello Antinori

    Version of Record online : 27 JAN 2016, DOI: 10.1002/lt.24353

  14. You have free access to this content
    Reply:

    Hepatology

    Volume 49, Issue 2, February 2009, Pages: 703–704, Peter Ferenci

    Version of Record online : 11 DEC 2008, DOI: 10.1002/hep.22782

  15. You have free access to this content
    Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitor

    Hepatology

    Volume 59, Issue 6, June 2014, Pages: 2423–2424, Alan S. Wang, Ruth M. Pfeiffer, Timothy R. Morgan and Thomas R. O'Brien

    Version of Record online : 14 APR 2014, DOI: 10.1002/hep.26771

  16. You have free access to this content
    Reply:

    Hepatology

    Volume 46, Issue 4, October 2007, Pages: 1308–1309, Thierry Thévenot, Vincent Di Martino and Françoise Lunel-Fabiani

    Version of Record online : 25 SEP 2007, DOI: 10.1002/hep.21944

  17. You have free access to this content
    Might rapid virological response be used as a stopping rule in liver transplant recipients treated with pegylated interferon plus ribavirin?

    Liver Transplantation

    Volume 14, Issue 9, September 2008, Pages: 1383–1384, Maria Francesca Donato, Francesca Agnelli, Cristina Rigamonti, Eliana Arosio and Massimo Colombo

    Version of Record online : 28 AUG 2008, DOI: 10.1002/lt.21570

  18. You have free access to this content
    Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy

    Hepatology

    Volume 52, Issue 3, September 2010, Pages: 1170–1171, Alessio Aghemo, Maria Grazia Rumi, Stella De Nicola and Massimo Colombo

    Version of Record online : 23 MAR 2010, DOI: 10.1002/hep.23685

  19. You have free access to this content
    Metformin improves sustained virologic response in difficult-to-cure hepatitis C: More questions than answers

    Hepatology

    Volume 51, Issue 3, March 2010, Page: 1082, Chia-Chi Wang and Jia-Horng Kao

    Version of Record online : 28 JAN 2010, DOI: 10.1002/hep.23546

  20. You have free access to this content
    “Real-Life” comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1453–1454, Julian Schulze zur Wiesch, Neele Pudelski, Lena Hoepner, Michael Supplieth, Peter Buggisch, Ansgar W. Lohse and Stefan Lüth

    Version of Record online : 7 APR 2011, DOI: 10.1002/hep.24185